MedTrace Logo

Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery

NCT02210949 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2017-04-05

No results posted yet for this study

Summary

Pre-treatment of patients with erythropoietin subcutaneously and iron supplement intravenously, in order to create a clinical pathway to minimize transfusion of red blood cells in a selected group of cardiac patients with an increased risk for blood transfusions in our cardiac surgery program.

Conditions

  • Heart; Dysfunction Postoperative, Cardiac Surgery
  • Anemia, Iron-Deficiency

Interventions

DRUG

Erythropoietin subcutaneously and Iron intravenously

Administration of Erythropoietin subcutaneously and administration of iron intravenously

Sponsors & Collaborators

  • Catharina Ziekenhuis Eindhoven

    lead OTHER

Principal Investigators

  • Marius C Haanschoten, MD · Catharina Ziekenhuis Eindhoven the Netherlands

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02210949 on ClinicalTrials.gov